T1	Participants 72 87	type 2 diabetes
T2	Participants 135 185	African Americans with diabetic ketoacidosis (DKA)
T3	Participants 437 711	eight obese African Americans with KPDM, eight obese subjects with type 2 diabetes with severe hyperglycemia without ketosis (ketosis-resistant type 2 diabetes), and nine nondiabetic obese control subjects underwent intravenous infusion of 20% intralipid at 40 ml/h for 48 h
